Arteris, Inc. (AIP) stock
AIPNasdaqSemiconductors & Related DevicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30120% above fair value
$19.34−0.85 (-4.21%)
Close on Nov 13, 2026Market cap $950.60MP/E –Yield –
Arteris r&d expenses
Research and development expenses are spending on new products and technology.
Arteris's R&D Expenses for the twelve months ending Sep 30, 2026 was $60.88M, up 26.3% year over year. For fiscal 2025 it was $49.91M, up 10.9% from the year before. The highest annual figure on record is $49.91M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.91M | +10.9% |
| FY2024 | Dec 31, 2024 | $45.01M | -0.3% |
| FY2023 | Dec 31, 2023 | $45.13M | +9.6% |
| FY2022 | Dec 31, 2022 | $41.17M | +33.6% |
| FY2021 | Dec 31, 2021 | $30.81M | +81.0% |
| FY2020 | Dec 31, 2020 | $17.02M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.43M | +29.9% |
| Q2 FY2026 | Jun 30, 2026 | $16.76M | +37.7% |
| Q1 FY2026 | Mar 31, 2026 | $14.46M | +21.9% |
| Q4 FY2025 | Dec 31, 2025 | $13.23M | +14.7% |
| Q3 FY2025 | Sep 30, 2025 | $12.65M | +6.1% |
| Q2 FY2025 | Jun 30, 2025 | $12.17M | +13.6% |
| Q1 FY2025 | Mar 31, 2025 | $11.86M | +9.5% |
| Q4 FY2024 | Dec 31, 2024 | $11.53M | +8.1% |
| Q3 FY2024 | Sep 30, 2024 | $11.92M | +8.4% |
| Q2 FY2024 | Jun 30, 2024 | $10.72M | -11.3% |
| Q1 FY2024 | Mar 31, 2024 | $10.84M | -4.8% |
| Q4 FY2023 | Dec 31, 2023 | $10.66M | +3.3% |
| Q3 FY2023 | Sep 30, 2023 | $11.00M | -0.2% |
| Q2 FY2023 | Jun 30, 2023 | $12.09M | +16.5% |
| Q1 FY2023 | Mar 31, 2023 | $11.38M | +20.4% |
| Q4 FY2022 | Dec 31, 2022 | $10.32M | +0.8% |
| Q3 FY2022 | Sep 30, 2022 | $11.02M | +44.9% |
| Q2 FY2022 | Jun 30, 2022 | $10.37M | +61.4% |
| Q1 FY2022 | Mar 31, 2022 | $9.46M | +44.6% |
| Q4 FY2021 | Dec 31, 2021 | $10.24M | +97.8% |
| Q3 FY2021 | Sep 30, 2021 | $7.61M | +89.7% |
| Q2 FY2021 | Jun 30, 2021 | $6.43M | – |
| Q1 FY2021 | Mar 31, 2021 | $6.54M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.18M | – |
| Q3 FY2020 | Sep 30, 2020 | $4.01M | – |
See a number that looks wrong?